Review Examines Inappropriate Prescribing of IV Fluids

This article originally appeared here.
Share this content:
Review Examines Inappropriate Prescribing of IV Fluids
Review Examines Inappropriate Prescribing of IV Fluids

TUESDAY, June 16, 2015 (HealthDay News) -- Inappropriate prescribing of intravenous (IV) fluids most often involves incorrect volumes and types of IV fluids prescribed, according to a review published online June 11 in the Journal of Clinical Pharmacy and Therapeutics.

X. Gao, from The First Affiliated Hospital in Guangzhou, China, and colleagues conducted a systematic review to examine inappropriate prescribing of IV fluids in adult patients.

The researchers found that the most common type of inappropriate prescribing was incorrect volumes and types of IV fluids prescribed, classified as misprescribing. Patients on IV fluid therapy were often prescribed a greater volume of fluid and amount of sodium in excess of normal requirements. Before prescribing IV fluids, doctors did not always check body weight, serum electrolyte level, and serum creatinine. Incomplete/incorrect prescription writing was also another common type of inappropriate prescribing. Insufficient knowledge and training of prescribers could cause these common inappropriate prescribing practices. Ignorance of the importance of IV fluid also contributed to inappropriate prescribing behaviors.

"There is an urgent need to make doctors aware of these problems and enhance appropriate training on IV fluid prescribing, especially on the appropriate volume and amount of electrolytes," the authors write. "Pharmacists could exert a role in reviewing the fluid prescription chart for improving clinical practice."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »